Skip to content

Preoperative Gabapentin for Chronic Pain After Thoracotomy (GABATHOMIE).

CompletedPhase 3NCT03158376
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

To assess the effects of prolonged preoperative gabapentin treatment (10 days) on chronic pain after thoracotomy.

Study details

Official title
Perioperative Gabapentin for Chronic Post-thoracotomy Pain: a Randomized, Double Blind, Placebo-controlled Study.
Sponsor
University Hospital, Lille
Collaborators
University of Lille Nord de France
Start date
2015-09
Primary completion
2019-05-24
Sex
All
Age range
from 18 Years
Results posted
No results posted in this snapshot
Countries
France
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * age \> 18 years * elective lung resection via thoracotomy Exclusion Criteria: * extended pleurectomy and chest wall resection * previous ipsilateral thoracotomy * previous ipsilateral radiotherapy * thoracotomy for pyothorax * chest injury * palliative surgery * contraindicated placement of a thoracic epidural catheter * allergy to medications on protocol * pre-existing pain syndrome * current treatment with morphine, gabapentin, pregabalin, anticonvulsivants or tricyclic antidepressants * a history of past or current drug addiction * severe hepatic, renal or cardiovascular disorders * inability to understand the study protocol or to answer the questionnaires on pain and quality of life * severe psychiatric disorders * incompetent adults under some form of guardianship * refusal of the protocol * persons without social security coverage * pregnant or lactating woman

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03158376